Compare PHR & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHR | NEOG |
|---|---|---|
| Founded | 2005 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 713.2M | 2.3B |
| IPO Year | 2019 | 1995 |
| Metric | PHR | NEOG |
|---|---|---|
| Price | $12.26 | $11.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 4 |
| Target Price | ★ $30.65 | $10.67 |
| AVG Volume (30 Days) | 2.0M | ★ 2.6M |
| Earning Date | 03-09-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.36 | N/A |
| EPS | 0.02 | ★ 0.09 |
| Revenue | $419,813,000.00 | ★ $894,661,000.00 |
| Revenue This Year | $15.56 | N/A |
| Revenue Next Year | $15.08 | $1.67 |
| P/E Ratio | $614.75 | ★ $124.61 |
| Revenue Growth | ★ 17.83 | N/A |
| 52 Week Low | $11.31 | $3.87 |
| 52 Week High | $32.76 | $11.43 |
| Indicator | PHR | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 38.70 | 66.35 |
| Support Level | $11.58 | $10.37 |
| Resistance Level | $12.79 | N/A |
| Average True Range (ATR) | 0.64 | 0.37 |
| MACD | 0.18 | -0.07 |
| Stochastic Oscillator | 64.19 | 73.85 |
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.